The behavioural neurology assessment

Canadian Journal of Neurological Sciences

Volumn 32, Issue 2, 2005, Pages 167-177

  Darvesh, S ^a   Leach, L ^b   Black, S E ^c,e,f   Kaplan, E ^b,g,h   Freedman, Morris ^b,c,d,f  

^a DALHOUSIE UNIVERSITY   (Canada)

^b BAYCREST CENTRE FOR GERIATRIC CARE   (Canada)

^c ROTMAN RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g SUFFOLK UNIVERSITY   (United States)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; BEHAVIORAL NEUROLOGY ASSESSMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; EDUCATION; FEMALE; FRONTOTEMPORAL DEMENTIA; HANDEDNESS; HUMAN; LANGUAGE; MALE; MEMORY; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; PREDICTION; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; VALIDATION PROCESS;

EID: 20544471429     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100003930     Document Type: Article

References (20)

1. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
2. Shulman KI, Feinstein A. Quick Cognitive Screening for Clinicians: Mini Mental, Clock Drawing and other Brief Tests. London, England: Martin Dunitz Publishers, 2003.
3. Kiernan RJ, Mueller J, Langston JW, Van Dyke C. The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann Int Med 1987; 107:481-485.
4. Schwamm LH, Van Dyke C, Kiernan RJ, Merrin EL, Mueller J. The Neurobehavioral Cognitive Status Examination: comparison with the Cognitive Capacity Screening Examination and the Mini-Mental State Examination in a neurosurgical population. Ann Int Med 1987; 107:486-491.
5. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc 1992; 40:922-935.
6. Meiran N, Stuss DT, Guzman DA, Lafleche G, Willmer J. Diagnosis of dementia: methods for the interpretation of scores of 5 neuropsychological tests. Arch Neurol 1996; 53:1043-1054.
7. Stuss DT, Meiran N, Guzman DA, Lafleche G, Willmer J. Do long tests yield a more accurate diagnosis of dementia than short tests? A comparison of 5 neuropsychological tests. Arch Neurol 1996; 53:1033-1039.
8. Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology 2000; 55:1613-1620.
9. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000; 55:1621-1626.
10. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 1987; 48:314-318.
11. Tombaugh TN, McDowell I, Kristjansson B, Hubley AM. Mini-Mental State Examination (MMSE) and the Modified MMSE (3MS): A Psychometric Comparison and Normative Data. Psychol Assess 1996; 8:48-59.
12. Lezak MD. Neuropsychological assessment,. 3rd ed. New York: Oxford University Press, 1995.
13. Strub RL, Black FW. The Mental Status Examination in Neurology, 3rd ed. Philadelphia: FA Davis Company, 1993.
14. Zakzanis KK, Leach L, Kaplan E. Neuropsychological Differential Diagnosis. Lisse, Netherlands: Swets & Zeitlinger, 1999.
15. DSM-IV. Diagnostic and Statistical Manual of Mental Disorders. 1994. Washington, DC, American Psychiatric Association.
16. Monsch AU, Bondi MW, Salmon DP, et al. Clinical validity of the Mattis Dementia Rating Scale in detecting dementia of the Alzheimer type. Arch Neurol 1995; 52:899-904.
17. Hogan DB, Ebly EM. Predicting who will develop dementia in a cohort of Canadian Seniors. Can J Neurol Sci 2000; 27:18-24.
18. Grutzendler J, Morris JC. Cholinesterase inhibitors for Alzheimer's disease. Drugs 2001; 61:41-52.
19. Giacobini E. From molecular structure to Alzheimer therapy. Jpn J Pharmacol 1997; 74:225-241.
20. Krall WJ, Sramek JJ, Cutler NR. Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease. Ann Pharmacother 1999; 33:441-450.